future treatment strategies for mpns
Published 3 years ago • 244 plays • Length 2:29Download video MP4
Download video MP3
Similar videos
-
1:14
an overview of the current and future treatment landscape for mpns
-
1:49
advances in the science and treatment of mpns
-
2:16
current and future treatment approaches for hr-mds
-
2:06
an insight into the challenges and management of myeloproliferative neoplasm-unclassifiable (mpn-u)
-
1:05
the future of managing precursor conditions
-
58:27
laboratory nonconformance (event) management
-
13:48
understanding treatment options for et, pv, and myelofibrosis
-
29:48
the future of molecular dynamics
-
3:37
the future of aml treatment
-
1:31
promising agents under investigation for the treatment of myelofibrosis with cytopenia
-
1:36
current and future treatment options for patients with myelofibrosis who have anemia
-
1:04
the future of mds management
-
2:09
advances in the management of fit adults with aml
-
2:06
outcomes & promising treatment options following hma failure in patients with hr-mds
-
1:21
future treatment priorities for high-risk mds
-
2:18
treating patients with advanced-stage hl in the frontline and relapsed settings in 2024
-
2:52
jak inhibitor combination therapy for the treatment of myelofibrosis
-
4:48
an insight into the management of cytopenias in mf
-
1:16
the future of ambulatory care in the treatment of hematological conditions and malignancies
-
1:00
how genomic testing has influenced treatment approaches and clinical trial design in mpns
-
2:17
insights into the real-world efficacy of luspatercept in patients with lr-mds
-
1:33
the current guidelines and therapies for tp53-mutated mds and aml